⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Biogen Completes Acquisition of Alcyone Therapeutics
globenewswire.com
BIIB
IONS
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
globenewswire.com
BIIB
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
globenewswire.com
BIIB
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
globenewswire.com
BIIB
Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors
prnewswire.com
BIIB
IFF
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
businesswire.com
STOK
BIIB
STOK
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
globenewswire.com
BIIB
New clinical data on lecanemab to be presented at CTAD conference 2026
prnewswire.com
BIIB
Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference
prnewswire.com
BIIB
LUNGevity Foundation Launches Every Breath Forward℠ to Advance Progress and Improve Lives Nationwide
prnewswire.com
BIIB
AZN
JNJ
AMGN
LLY
MRK
REGN